Source: PR Newswire

Press Release: AbbVie : AbbVie Inc. - Despatch of Option Holder Proposal Letters

NORTH CHICAGO, Ill., Sept. 20, 2019 /PRNewswire/ -- In accordance with Rule 15(c) of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. ("AbbVie") and Allergan plc ("Allergan") announce that letters dated 20 September 2019 containing details of the proposal (the...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from AbbVie's latest SEC filings

Annual Revenue

Based on data from AbbVie's latest SEC filings


Richard A. Gonzalez's photo - Chairman & CEO of AbbVie

Chairman & CEO

Richard A. Gonzalez

CEO Approval Rating


AbbVie discovers, develops and markets both biopharmaceuticals and small molecule drugs.

AbbVie's headquarters is located...
Read more